Logo.jpg
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023
09 nov. 2023 08h00 HE | ProPhase Labs, Inc.
Company sees significant momentum in Pharmaloz, Nebula Genomics and ProPhase BioPharma Pharmaloz Manufacturing plans on track to increase capacity from $10 million to over $75 million in 2024...
Logo.jpg
Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
29 juin 2023 08h00 HE | ProPhase Labs, Inc.
Garden City, NY, June 29, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next generation biotech, genomics and diagnostics company, today announced that it recently made...
Logo.jpg
ProPhase Labs Announces Launch of Redesigned Corporate Website
25 avr. 2023 08h30 HE | ProPhase Labs, Inc.
Garden City, NY, April 25, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today announced the launch of its...